Searched over 200M research papers
7 papers analyzed
These studies suggest that chronic cough and phlegm lasting for months should be evaluated for potential causes, with factors such as smoking, socioeconomic status, and underlying respiratory conditions being significant considerations.
20 papers analyzed
Chronic cough and phlegm are common symptoms that can significantly impact quality of life. A study conducted in Italy found that 11.9% of young adults aged 20-44 reported chronic cough and phlegm, with a slightly higher prevalence in females (12.0%) compared to males (11.8%). Key risk factors identified include smoking, female gender, and low socioeconomic status. Similarly, a Japanese study reported a prevalence of 1.7% among adults aged 40 and above, with a significant portion of these individuals being current smokers.
The definition of chronic cough varies across studies, which complicates diagnosis and treatment. Epidemiological studies often define chronic cough as lasting three months or more, while clinical guidelines typically use an eight-week cutoff. This discrepancy highlights the need for standardized definitions to improve diagnosis and treatment consistency.
Chronic cough and phlegm are early indicators of COPD, providing an opportunity for early intervention before significant airflow obstruction occurs. Screening for these symptoms in routine health examinations can help identify at-risk individuals, particularly smokers, and facilitate early management strategies.
In patients with SSc-ILD, chronic cough is a prevalent symptom, affecting 73% of patients in a study from the Scleroderma Lung Study. The severity of cough in these patients correlates with the extent of lung fibrosis, and treatment with cyclophosphamide has been shown to reduce cough frequency, although the effect diminishes after discontinuation of the treatment.
Chronic cough can lead to various complications, including exhaustion, irritability, headaches, and difficulty sleeping. It can also cause significant psychological distress, making it essential to address both the physical and emotional aspects of the condition.
A study investigating the effects of a standardized extract composed of Atractylodis Rhizoma Alba and Fructus Schisandrae found that it could reduce cough frequency and facilitate phlegm expectoration by inhibiting inflammatory mediators and enhancing mucociliary clearance. This suggests potential benefits for using herbal extracts in managing chronic cough and phlegm.
Given the strong association between smoking and chronic cough, smoking cessation is a critical component of managing these symptoms. Studies consistently show that a significant proportion of individuals with chronic cough and phlegm are current smokers, emphasizing the need for targeted smoking cessation programs .
Chronic cough and phlegm are prevalent symptoms with significant implications for respiratory health. Understanding the risk factors, standardizing definitions, and implementing effective treatment strategies, including smoking cessation and potential herbal remedies, are essential steps in managing these conditions. Early identification and intervention can improve outcomes and quality of life for affected individuals.
Most relevant research papers on this topic